Hhlr Advisors, Ltd. I Mab Transaction History
Hhlr Advisors, Ltd.
- $2.42 Billion
- Q2 2025
A detailed history of Hhlr Advisors, Ltd. transactions in I Mab stock. As of the latest transaction made, Hhlr Advisors, Ltd. holds 5,980,568 shares of IMAB stock, worth $23 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
5,980,568
Previous 5,980,568
-0.0%
Holding current value
$23 Million
Previous $4.9 Million
195.11%
% of portfolio
0.6%
Previous 0.15%
Shares
6 transactions
Others Institutions Holding IMAB
# of Institutions
40Shares Held
14.2MCall Options Held
10.2KPut Options Held
0-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$16 Million3.04% of portfolio
-
Candriam S.C.A.1.13MShares$4.36 Million0.02% of portfolio
-
Sg Americas Securities, LLC876KShares$3.37 Million0.01% of portfolio
-
International Biotechnology Trust PLC London, X0310KShares$1.2 Million0.14% of portfolio
-
Edbi Pte LTD Singapore, U0222KShares$855,2230.2% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $320M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...